Marina Elena Cazzaniga (M E Cazzaniga, Marina Cazzaniga, Marina E Cazzaniga)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 10

Top Topics

Metastatic Breast Cancer

Small Cell Lung Cancer

Top Venues

Breast cancer research and treatment

Journal of clinical medicine

Infection and drug resistance

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Marina Elena Cazzaniga, Serena Capici, Nicoletta Cordani, Viola Cogliati, Francesca Fulvia Pepe, Francesca Riva, Maria Grazia Cerrito
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows. Journal of clinical medicine 11 (16) (2022)
Selena Russo, Marco Bani, Marco Terraneo, Valeria Quaglia, Giampaolo Nuvolati, Rebecca Cavaliere, Serena Capici, Marina Elena Cazzaniga, Maria Grazia Strepparava
Why not? Motivations for entering a volunteer register for clinical trials during the COVID-19 pandemic. European journal of clinical pharmacology 78 (11) (2022)
Francois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, Guillermo Streich, Alberto J Montero, Frédéric Forget, Marie-Ange Mouret-Reynier, Joo Hyuk Sohn, Donatienne Taylor, Kathleen K Harnden, Hung T Khong, Judit Kocsis, Florence Dalenc, Patrick M Dillon, Sunil Babu, Simon H Waters, Ines Deleu, José A García Sáenz, Emilio Bria, Marina Elena Cazzaniga, Janice Lu, Philippe Aftimos, Javier Cortes, Shubin Liu, Giulia Tonini, Dirk Laurent, Nassir Habboubi, Maureen G Conlan, Aditya Bardia
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)
Viola Cogliati, Serena Capici, Francesca Fulvia Pepe, Pierluigi di Mauro, Francesca Riva, Federica Cicchiello, Claudia Maggioni, Nicoletta Cordani, Maria Grazia Cerrito, Marina Elena Cazzaniga
How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story. Life (Basel, Switzerland) 12 (3) (2022)
Rosalba Torrisi, Raffaella Palumbo, Rita De Sanctis, Patrizia Vici, Giulia Valeria Bianchi, Laura Cortesi, Vita Leonardi, Rossana Gueli, Alessandra Fabi, Maria Rosaria Valerio, Anna Rita Gambaro, Barbara Tagliaferri, Laura Pizzuti, Marina Elena Cazzaniga, Armando Santoro
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9). Breast cancer research and treatment 190 (1) (2021)
Serena Capici, Luca Sala, Stefania Galimberti, Maria Grazia Valsecchi, Nicola Squillace, Giulia Gustinetti, Marina Elena Cazzaniga, Bonfanti Paolo
The Role for Tocilizumab in COVID-19 Patients: Reflections on Monza Cohort Data. Infection and drug resistance 14 (2021)
Marina Elena Cazzaniga, I Vallini, E Montagna, D Amoroso, R Berardi, A Butera, K Cagossi, L Cavanna, M Ciccarese, S Cinieri, E Cretella, E De Conciliis, A Febbraro, F Ferraù, A Ferzi, A Baldelli, A Fontana, A R Gambaro, O Garrone, V Gebbia, D Generali, L Gianni, F Giovanardi, A Grassadonia, V Leonardi, P Marchetti, S Sarti, A Musolino, M Nicolini, C Putzu, F Riccardi, D Santini, S Saracchini, M G Sarobba, M G Schintu, G Scognamiglio, P Spadaro, C Taverniti, D Toniolo, P Tralongo, A Turletti, R Valenza, M R Valerio, P Vici, P Di Mauro, V Cogliati, S Capici, L Clivio, V Torri, null null
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study. Breast cancer research and treatment 190 (3) (2021)
Marina Elena Cazzaniga, Romano Danesi, Corrado Girmenia, Pietro Invernizzi, Alessandra Elvevi, Massimo Uguccioni, null null
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success. Breast cancer research and treatment 176 (3) (2019)
Marina Elena Cazzaniga, Elisabetta Munzone, Guido Bocci, Noémia Afonso, Patricia Gomez, Sven Langkjer, Edgar Petru, Xavier Pivot, Pedro Sánchez Rovira, Piotr Wysocki, Valter Torri
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project. Advances in therapy 36 (2) (2018)
Marina Elena Cazzaniga, L Cortesi, A Ferzi, L Scaltriti, F Cicchiello, M Ciccarese, S Della Torre, F Villa, M Giordano, C Verusio, M Nicolini, A R Gambaro, L Zanlorenzi, E Biraghi, E Casini, L Legramandi, Eliana Rulli
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now? International journal of breast cancer 2017 (2017)